Sir Run Run Shaw Hospital
- Country
- People's Republic of China
- Ownership
- Private
- Established
- 1994-01-01
- Employees
- -
- Market Cap
- -
Clinical Trials
101
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (80 trials with phase data)• Click on a phase to view related trials
Exploring the Safety and Efficacy of Sacituzumab Tirumotecan Combined With Pucotenlimab in the Treatment of Advanced Cholangiocarcinoma
- Conditions
- Cholangiocarcinoma
- Interventions
- Drug: Sacituzumab tirumotecan (iv)+Putolizumab injection (iv)
- First Posted Date
- 2025-08-06
- Last Posted Date
- 2025-08-06
- Lead Sponsor
- Sir Run Run Shaw Hospital
- Target Recruit Count
- 59
- Registration Number
- NCT07105852
- Locations
- 🇨🇳
Sir Run Run Shaw Hospital, Zhejiang University School of Medicine (Qingchun Campus) 3 Qingchun Road East, Shangcheng District, Hangzhou, Zhejiang, China, Hangzhou, Zhejiang, China
Node-Sparing Short-Course Radiation Combined With Capecitabine and PD-1/CTLA-4 for MSS Early Rectal Cancer
- Conditions
- Rectal Cancer
- Interventions
- Radiation: Lymph-node-sparing short-course radiotherapyDrug: PD-1/CTLA-4 inhibitor (Aiparolitoworixureli injection)
- First Posted Date
- 2025-07-16
- Last Posted Date
- 2025-07-30
- Lead Sponsor
- Sir Run Run Shaw Hospital
- Target Recruit Count
- 52
- Registration Number
- NCT07068763
Early Endovascular Treatment in Isolated Internal Carotid Artery Occlusion
- Conditions
- Stroke, Acute Ischemic
- Interventions
- Procedure: Endovascular treatmentDrug: The best medical treatment
- First Posted Date
- 2025-06-12
- Last Posted Date
- 2025-06-12
- Lead Sponsor
- Sir Run Run Shaw Hospital
- Target Recruit Count
- 140
- Registration Number
- NCT07016854
- Locations
- 🇨🇳
Sir Run Run Shaw Hospital, Hangzhou, Zhejiang, China
Diaphragmatic Speckle Tracking to Guide Diaphragm-Protective Ventilatory Support: A Study of Feasibility and Efficacy.
- Conditions
- Respiratory Failure
- First Posted Date
- 2025-05-30
- Last Posted Date
- 2025-07-15
- Lead Sponsor
- Sir Run Run Shaw Hospital
- Target Recruit Count
- 400
- Registration Number
- NCT06996665
- Locations
- 🇨🇳
Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hang zhou, Zhejiang, China
Home Oscillatory Positive Expiratory Pressure - Aerobic Exercise Rehabilitation Study
- Conditions
- COPDAECOPD
- First Posted Date
- 2025-05-14
- Last Posted Date
- 2025-05-14
- Lead Sponsor
- Sir Run Run Shaw Hospital
- Target Recruit Count
- 312
- Registration Number
- NCT06970054
- Locations
- 🇨🇳
Sir Run Run Shaw Hospital Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
- Prev
- 1
- 2
- 3
- 4
- 5
- 20
- Next
News
Tenecteplase Investigated for Preventing Myocardial Infarction Post-PCI
A randomized controlled trial is set to evaluate intracoronary tenecteplase (TNK) for preventing periprocedural myocardial infarction (PMI) in CAD patients undergoing PCI.